BUYER READINESS
A layer underneath, not a ninth letter.
If you run MEDDPICC and your forecast still slips on deals where every letter is green, you're not running a worse MEDDPICC. You're running the most complete qualification instrument in B2B without the diagnostic layer underneath. This page covers what each measures, where MEDDPICC's newer letters come closest to the buyer's side, and when buyer readiness work is premature versus overdue. The sister analysis is at what MEDDIC cannot see.
Here's the shape of it, from a case I keep on file. It's an anonymized composite assembled from sales-community accounts, not a client of mine, and I'd rather tell you that than let you assume otherwise. A purchase needed sign-off from a group of five where everyone held a veto and nobody held the pen. All five were fine with it. Not one of them was against it, not once, across four months. But fine, from five people with no decision owner, produces no decision, and every meeting closed the same way it opened, on an agreement to think about it a bit more. Nobody ever said no. The signature just never came, and the initiative quietly went away.
Now read it back through the scorecard. Economic Buyer: named. Champion: engaged. Decision Criteria: documented. Decision Process: mapped. Paper Process: mapped, never the constraint. Pain: implicated, nobody disputed it. Metrics: agreed. Competition: none. Eight fields, eight greens, one dead deal. The scorecard was complete and the forecast was still wrong.
What that costs isn't one deal. It holds its slot in commit while it dies, so the number stays in the forecast until the quarter closes around it. The rep gets coached on discovery already done and already green. The account gets re-worked next quarter at full cost, and the loop repeats, because nothing on the scorecard could have flagged it.
Coverage records what the seller did.
That's its whole job, and it does it well. The deals that die anyway are covered at why qualified deals die, and the volume-without-conviction version at why your demo pipeline is growing and your close rate isn't.
The pillar lives at /buyer-readiness. Sibling head-to-heads: vs MEDDIC, vs BANT, vs Challenger, vs SPIN.
What MEDDPICC Measures, and What It Does Not
MEDDIC was created inside PTC in 1996 by Dick Dunkel, under SVP John McMahon, alongside Jack Napoli. The extra letters came later, from practice. No source I can find names a person or a year for Paper Process and the second C, so I won't give you one. Andy Whyte's book standardized the vocabulary the market now uses, and meddicc.com is the framework's closest thing to a canonical reference.
What MEDDPICC measures and prescribes
- Metrics. The quantifiable value you can provide, in the buyer's own numbers.
- Economic Buyer. Whoever holds budget authority here, which isn't always who the org chart points at.
- Decision Criteria. The standards the organization says it will judge against.
- Decision Process. How the buyer decides.
- Paper Process. Everything that happens after the decision and before the signature.
- Implicate the Pain. Not just found. Made to land.
- Champion. Someone inside the account with real influence and the credibility to spend it.
- Competition. Any alternative. A vendor, an internal build, another initiative chasing the budget.
Eight fields, and every one is worth filling in. That's not a concession before the real argument. It's the argument.
The hidden assumption
MEDDPICC assumes the missing variable is always a field the seller hasn't filled in yet. Every extension follows that logic: Paper Process because deals died after the decision, Competition because reps got blindsided. Both were correct diagnoses, answered the same way, by adding coverage.
That assumption deserves a fair test rather than an accusation, and MEDDPICC is the fairest one going. Twenty years of practitioners adding what they found missing is the strongest version of the seller-side hypothesis anyone has built.
The letter nobody agrees on
There's a genuine disagreement about MEDDPICC's I, and it's load-bearing. The canonical source expands it to Implicate the Pain, an active standard the seller has to meet. Much of the market still reads it as MEDDIC's original Identify Pain, a passive one.
I won't build a case on that disagreement, because pointing at it would be cheap. It matters for one reason: on the stronger reading, the I is the closest any qualification framework comes to measuring buyer belief, and the rest of this page turns on how close that is.
What DecisionScope Measures
The four readiness dimensions
- Problem Conviction. Belief that the problem justifies action. You'll recognize the gap when a buyer agrees the problem is real and never treats it as urgent.
- Evaluation Clarity. A framework for comparing options. The gap shows up as an evaluation that keeps widening, with new requirements at every meeting, the pattern covered at the buyer drowning in options.
- Outcome Confidence. Trust that the solution will work in their environment. You'll see it as a successful pilot followed by doubt at scale.
- Organizational Readiness. Internal alignment across stakeholders. It shows up as a champion who's convinced and can't move the room.
The four form a chain, and the deal moves at the speed of the weakest link. Three maxed and one incomplete isn't a strong deal with a minor gap. Be clear on that claim's status: each dimension rests on cited research, but the chain model on top of them hasn't got a controlled trial behind it. I state it because the indecision literature predicts it, not because anyone ran the experiment.
The four resolution protocols
- Urgency Protocol. Builds the case for change before the first sales conversation, closing Problem Conviction.
- Framework Protocol. Supplies decision structure the buyer trusts before evaluation, closing Evaluation Clarity.
- Proof Protocol. Supplies implementation evidence in the buyer's context, closing Outcome Confidence.
- Alignment Protocol. Maps the buying group and equips the champion to sell internally, closing Organizational Readiness. The opening deal needed this one.
The research foundation
- Between 40% and 60% of qualified B2B deals end in no decision, and 56% of those losses come from buyer indecision rather than preference for the status quo (Dixon and McKenna, Harvard Business Review, 2022).
- 86% of B2B purchases stall during the buying process (Forrester, 2024).
- The average B2B buying group runs to 13 stakeholders (Forrester), and 74% of buying teams sit in unhealthy conflict (Gartner).
None of those numbers describe a seller-skill gap. Every source behind them is listed with tier ratings and the findings that cut against the thesis in the full source table.
Where They Overlap, and Where They Diverge
The comparison
| Axis | MEDDPICC | DecisionScope |
|---|---|---|
| What it measures | Whether the seller has covered the deal | Whether the buyer can complete the decision |
| Whose side | Yours, thoroughly | Theirs |
| Scope | Qualification, end to end through signature | Buyer readiness across four dimensions |
| Output | Covered or not covered, letter by letter | A score per dimension, plus the weakest link |
| Who supplies the answer | Your rep, from what they observed | The buyer's state, scored against evidence |
| When it runs | Continuously through the cycle | Before the cycle, and diagnostically during |
| Failure it catches | Procurement drag, unnamed competitors, unimplicated pain | Buyer cannot finish the decision |
| Failure it misses | Indecision inside a fully covered deal | Whether the deal was worth qualifying at all |
| What you do with it | Pursue, deprioritize, or disqualify | Run the protocol matching the weakest dimension |
The verdict
MEDDPICC is MEDDIC after twenty years of practitioners adding the fields they kept finding missing. No qualification instrument in general use is more complete, and three of its eight letters reach toward the buyer further than anything else in the category. It still doesn't measure whether the buyer can decide. That isn't a flaw in MEDDPICC, and treating it as one is a category error. It's the strongest available evidence that buyer readiness is a separate measurement, because if two more decades of adding the missing field were going to produce it, MEDDPICC is the framework where it would have shown up. DecisionScope runs underneath qualification and answers the question the eight letters were never built to ask.
It can't tell you whether the buyer believes the problem justifies acting. It can't tell you whether the group can converge on anything. It can't tell you whether the yes has an owner.
The same model, framed from the seller's chair instead of the buyer's, is worked through in the buyer readiness gap.
Why the overlap is smaller than it looks
Decision Criteria and Decision Process look like they cover Evaluation Clarity. They don't, for the reason worked through on the MEDDIC comparison: what a buyer says they'll judge on is not what survives a committee. MEDDPICC inherits that gap, because neither added letter touches it.
When MEDDPICC Alone Is Enough
MEDDPICC is sufficient, and readiness work on top of it premature, in six situations:
- Short cycles. Under 30 days the buyer's state can't drift far, so coverage is close enough to readiness.
- A real named competitor. When the loss will be competitive, Competition is the field that matters and it's doing its job.
- Procurement-bound enterprise deals. Where Paper Process is the binding constraint, MEDDPICC measures the thing actually stopping you.
- Healthy win rates. Above 25% on qualified pipeline, losses are more likely competitive than indecisive.
- Mature categories. When buyers arrive already convinced, the conviction work happened upstream.
- Teams new to qualification discipline. MEDDPICC's coverage gain is the biggest improvement available, and a second instrument on top of an unpracticed first one buys confusion.
In each of these, layering DecisionScope on top adds friction without adding signal.
When You Need DecisionScope on Top
Five signals, any one of which is enough:
- Most losses are no-decision, not competitive. Ebsta and Pavilion put 61% of B2B losses down to buyer indecision. If your ratio looks like that, your instrument is measuring the wrong failure.
- Coverage is green and the forecast still slips. The pattern this page opened on. Nothing is wrong, and the deals die anyway.
- Deals go quiet after a strong meeting, no objection raised. People actively avoid useful information when it threatens existing beliefs or forces a hard decision (Golman, Hagmann and Loewenstein, Journal of Economic Literature, 2016). Silence after a good call is often that, not lost interest.
- Your buying group is bigger than six. Win rates peak at four to five stakeholders and decline past six (Brontén and Cabrera, Journal of Systems Thinking, 2025), which is a variable no coverage field carries. The same problem in a leaner qualification frame is covered at DecisionScope vs BANT.
- Enthusiastic champions who can't move the room. Champion effectiveness rests on engagement, influence, credibility and capacity, plus organizational support (Bunce et al., Implementation Science, 2020). The Champion field records only that one exists.
Price it on your own numbers rather than mine.
- Pull the deals from the last four quarters that were green across all eight letters when they died.
- Multiply by the share that ended in no decision rather than a competitor win. Your CRM knows this number.
- Multiply by 61%, the share Ebsta and Pavilion attribute to indecision rather than a rival.
- Ask what recovering a quarter of that is worth against scoring four dimensions on deals you already qualified.
On $8M of fully covered pipeline at 45% no-decision, the line reads $8M, then $3.6M, then $2.2M, then $550K. Substitute your own three inputs. If it doesn't clear, this isn't your bottleneck, and the six conditions above are your answer.
Three Ways MEDDPICC Without Readiness Diagnostics Fails
These are the three letters that come closest to the buyer's side and stop short. Each is a near-miss, which is what makes it worth naming.
The pain you implicated and the buyer avoided
On the stronger reading, implicating pain is an active standard: the buyer has to feel it, not just acknowledge it. That's the closest a qualification framework gets to Problem Conviction, and it's still a record of what the seller did. The mechanism that separates the two is information avoidance, and a perfectly implicated pain can produce it rather than urgency.
That finding cuts at me too. If pressure on a reluctant buyer is the problem, then an Urgency Protocol is subject to the same test, and loss-framed messages are not reliably more persuasive than gain-framed ones across 53 studies (O'Keefe and Jensen, Journal of Communication, 2009). Making the pain vivid isn't a lever with a guaranteed direction. What actually separates a protocol from pressure is narrower and testable: avoidance drops when information is perceived as accurate and a mitigation path is visible (Cavlovic et al., Journal of Risk and Uncertainty, 2024). Evidence without a remedy produces avoidance. An Urgency Protocol that supplies the first and not the second has failed by the standard I just applied to somebody else's discovery call. More on that pattern at the buyer urgency problem.
Paper Process is the last mile, not the whole road
Paper Process catches real drag Decision Process misses, and adding it was correct. It's also the last mile of organizational readiness, and the only mile visible from outside the buyer. It carries none of the four characteristics that predict whether a champion can win, and not the shape of the group either. Durable group decisions come from a shared structured understanding across the group rather than persuading stakeholders one at a time (DeChurch and Mesmer-Magnus, meta-analysis, 2010), and no signature workflow measures whether that shared frame exists. The opening composite died here: not in procurement, but in the gap between five people agreeing and one person owning.
The Competition field reads “none” on the deal you are about to lose
Competition asks who else is in the room. On the deals most likely to die, the answer is nobody, because the dominant alternative in an indecision loss isn't a vendor. It's no decision, the 56% cited above. A faithfully completed C field reads clean on exactly the deal you're about to lose, and the economics are worked through at the cost of inaction. Where the rest of the revenue stack sits against this is mapped at the complete solution comparison.
How to Run Both Together
The combined workflow
- Qualify with MEDDPICC as you do now. Nothing gets dropped. Coverage is still the job, and it isn't the part that's failing.
- Score readiness separately. Four dimensions, scored against evidence rather than rep confidence, before the deal reaches commit.
- Match the weakest dimension to its protocol. Coverage says what you know; the score says which move to make.
- Problem Conviction incomplete. Run the Urgency Protocol before the next call, not a follow-up sequence.
- Evaluation Clarity incomplete. Run the Framework Protocol. Sending more material makes this worse.
- Outcome Confidence incomplete. Run the Proof Protocol against their environment, not a logo slide.
- Organizational Readiness incomplete. Run the Alignment Protocol and equip the champion for the room you'll never be in.
- Set the decision checkpoint. When coverage is green and the score is not, stop running the default play. Diagnosis alone closes at 14%; diagnosis plus a specific recommendation closes at 36% (Dixon and McKenna, 2022). The lift is in the prescription.
A short example
- Without a diagnostic. The five-person committee scores green on all eight letters. The rep reads unanimous mild approval as consensus and forecasts it. Four months of pleasant meetings, then nothing.
- With one. The same coverage, plus an Organizational Readiness score that flags a group with no decision owner. Now the pipeline review is a different meeting. You sort commit by readiness instead of by stage, see which deals are green on coverage and red on the buyer's side, and pull those out before the forecast locks. The move on this one changes from following up to naming the owner and equipping them, before the fourth meeting instead of after the twelfth. The forecast gets smaller and it gets true.
Same rep, same scorecard, different move.
Five people. Five vetoes. Eight green letters. Nobody holding the pen.
The scorecard on that deal was never wrong. It was pointed at the wrong side of the table, and it stayed there four months while everyone did their job correctly. Coverage tells you what you know. It can't tell you what your buyer can finish.
Take the Free Buyer Readiness Check
Between 40% and 60% of qualified B2B deals end in no decision. To find out whether that's happening inside your own green-scored pipeline, measure it against the four dimensions rather than against your coverage. Four minutes, no card, no call.
FAQ
Does DecisionScope replace MEDDPICC?
No. They measure opposite sides of the same deal, and the relationship is layered rather than competitive. MEDDPICC covers what is true on your side: metrics, the economic buyer, criteria, process, paper, pain, champion, competition. DecisionScope diagnoses what is true on the buyer's: conviction, clarity, confidence, and organizational alignment. A deal can score green on all eight letters and die because the buyer never finished deciding. That is the readiness gap. MEDDPICC has no field for it because it was never built to have one. Run both.
What do the extra P and second C in MEDDPICC actually add?
Paper Process covers what happens after the decision and before the signature, catching procurement and legal drag that Decision Process misses. Competition forces the rep to name every alternative, including internal initiatives competing for the same budget. Both close genuine gaps, and both are seller-side observations. They make the map of your own territory more complete. Neither opens the buyer's side, which is why this page's argument is specific to MEDDPICC rather than inherited from the MEDDIC comparison.
Does the I in MEDDPICC mean Identify Pain or Implicate the Pain?
Both are in active use, and the disagreement is real rather than sloppy sourcing. The canonical reference expands it to Implicate the Pain, an active standard the seller has to meet. Widely-used vendor references still carry the original Identify Pain. The difference matters: on the passive reading the field records that a pain exists, on the active one that the seller made the buyer feel it. Neither records whether the buyer now believes the problem justifies acting, which is what Problem Conviction is for.
Is MEDDPICC enough on its own for enterprise deals?
Often, yes, specifically when the binding constraint is procurement rather than decision-making. Long enterprise cycles with heavy paper are where Paper Process earns its place. The signal that it is not enough is your loss ratio: when most losses end in no decision rather than a competitor win, the instrument is measuring a failure you are not having. Check that in your own CRM before assuming your losses are competitive.
How is Organizational Readiness different from MEDDPICC's Paper Process?
Paper Process maps the workflow after the decision. Organizational Readiness measures whether the group can reach the decision that workflow assumes. A group can have an immaculate procurement path and never generate anything to send down it, which is what happens when win rates decline past six stakeholders or nobody owns the yes. Paper Process is the last mile. Organizational Readiness is the road.
Why do deals that score green on all eight MEDDPICC letters still end in no decision?
Because all eight record something the seller observed or did, and no decision is something the buyer fails to do. The common shape is a group that agrees and never converges: everyone approves, nobody owns it, agreement diffuses until it evaporates. That is the 40% to 60% of qualified deals that end without a competitor, and it is not a failure of discipline. It is a measurement pointed at the wrong side of the table.
How long does a DecisionScope assessment take?
The free Buyer Readiness Check takes four minutes and scores your pipeline against the four dimensions from your own read of it. A full diagnosis works from a real slice of your CRM. It names the weakest link, what that indecision costs you annually, and the protocol that resolves it.